Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis.

Vu T, Ortiz S, Katsuno M, Annane D, Mantegazza R, Beasley KN, Aguzzi R, Howard JF Jr

Open source

DOI
10.1007/s00415-023-11617-1
Published
2023 Jun
Container
Journal of neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00415-023-11617-1,
  title = {Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis.},
  author = {Vu T and Ortiz S and Katsuno M and Annane D and Mantegazza R and Beasley KN and Aguzzi R and Howard JF Jr},
  year = {2023},
  journal = {Journal of neurology},
  doi = {10.1007/s00415-023-11617-1},
  url = {https://doi.org/10.1007/s00415-023-11617-1}
}

RIS

TY  - JOUR
TI  - Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis.
AU  - Vu T
AU  - Ortiz S
AU  - Katsuno M
AU  - Annane D
AU  - Mantegazza R
AU  - Beasley KN
AU  - Aguzzi R
AU  - Howard JF Jr
PY  - 2023
JO  - Journal of neurology
DO  - 10.1007/s00415-023-11617-1
UR  - https://doi.org/10.1007/s00415-023-11617-1
ER  - 

APA

T, V., S, O., M, K., D, A., R, M., KN, B., R, A., & Jr, H. J. (2023). Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis.. Journal of neurology. https://doi.org/10.1007/s00415-023-11617-1

Source records